| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |